Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Director acquired 5,953,921 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 22,969 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 872,769 shares (grant or award)
  5. 4 Grant or award Chief Medical Officer, EVP R&D acquired 1,161,938 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 4 Shares withheld for taxes Former President and CEO gave up 14,250 shares (to pay taxes)
  12. 4 Shares withheld for taxes SVP and CFO gave up 8,548 shares (to pay taxes)
  13. 4 Shares withheld for taxes Former SVP, Gen. Counsel gave up 8,550 shares (to pay taxes)
  14. 8-K Event Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 10-Q Report Quarterly Report
  17. DEFA14A Proxy Proxy Materials
  18. DEFA14A Proxy Proxy Materials
  19. 8-K Event Other events
  20. DEFA14A Proxy Proxy Materials

Page 33 of 62 · 1,224 filings